查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451790

2024-2032 年按产品类型、程序类型、技术、应用和地区分類的生殖遗传学市场报告

Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年全球生殖遗传学市场规模达到57亿美元。展望未来， IMARC Group预计到2032年市场规模将达到501亿美元，2024-2032年复合年增长率（CAGR）为26.5%。大众对遗传性疾病的认识和理解不断增强、预防性医疗保健的普及以及生育率的提高导致辅助生殖技术（ART）的普及，这些都是推动市场发展的一些关键因素。

生殖遗传学是指专注于研究遗传讯息及其对生殖健康和结果影响的遗传学分支。它涉及对与生育、怀孕以及遗传疾病从父母传给后代相关的遗传因素的分析和理解。生殖遗传学涵盖旨在识别和管理生殖过程中遗传条件的各种技术和技术。对个人或夫妇进行特定基因突变或带因者状态筛检，以评估遗传性疾病遗传给子女的风险。在体外受精 (IVF) 等辅助生殖技术中，PGD 涉及在胚胎植入子宫之前对胚胎进行遗传异常分析，帮助选择没有特定遗传疾病的胚胎。生殖遗传学透过识别携带者状态或个人或夫妇是否存在特定基因突变，帮助评估将遗传性疾病传播给后代的风险。

生殖遗传学市场趋势：

全球市场主要是由大众对遗传性疾病的认识和理解不断增强所推动的。此外，预防性医疗保健的日益普及导致越来越多的准父母接受基因检测，以了解未来孩子遗传性疾病的风险，这也推动了市场的发展。随着生育率的不断提高，体外受精（IVF）和代孕等辅助生殖技术（ART）的采用率越来越高，这创造了一个积极的市场前景。与此一致的是，次世代定序（NGS）和高解析度微阵列等先进基因检测技术的不断发展正在刺激市场。此外，母亲年龄的增加导致女性更容易出现染色体异常，这也为市场提供了动力。除此之外，一些国家的政府越来越多地支持基因研究和测试，从而促进了市场的成长。基因组定序程序的可负担性不断提高，进一步推动了市场的发展，导致大众更容易获得。促进市场发展的其他一些因素包括收入水准的上涨（特别是在发展中国家）、提供直接面向消费者的基因测试的组织的激增、个性化医疗的持续创新以及广泛的研发（R&D）活动。

本报告回答的关键问题：

  • 迄今为止，全球生殖遗传学市场表现如何，未来几年将如何表现？
  • 全球生殖遗传学市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球生殖遗传学市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的生殖遗传学市场？
  • 依产品类型分類的市场是怎么样的？
  • 生殖遗传学市场上最具吸引力的产品类型是什么？
  • 根据手术类型，市场的划分是怎样的？
  • 生殖遗传学市场上最具吸引力的手术类型是什么？
  • 基于技术的市场区隔是什么？
  • 生殖遗传学市场上最具吸引力的技术是什么？
  • 基于应用程式的市场区隔是什么？
  • 生殖遗传学市场中最具吸引力的应用是什么？
  • 全球生殖遗传学市场的竞争结构如何？
  • 全球生殖遗传学市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生殖遗传学市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 套件
    • 市场走向
    • 市场预测
  • 实验室开发测试 (LDT)
    • 市场走向
    • 市场预测
  • 试剂及耗材
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按程序类型

  • 携带者筛检
    • 市场走向
    • 市场预测
  • 产前筛检
    • 市场走向
    • 市场预测
  • 植入前基因检测
    • 市场走向
    • 市场预测
  • 不孕症基因检测
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依技术

  • 下一代定序
    • 市场走向
    • 市场预测
  • 聚合酶炼式反应
    • 市场走向
    • 市场预测
  • 原位杂交 (ISH/FISH)
    • 市场走向
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按应用

  • 非整倍体
    • 市场走向
    • 市场预测
  • 染色体结构异常
    • 市场走向
    • 市场预测
  • 单基因疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bangkok Genomics Innovation Public Company Limited
    • Centogene NV
    • Fulgent Genetics Inc.
    • Igenomix (Vitrolife Group)
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A10134

The global reproductive genetics market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.1 Billion by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global reproductive genetics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, procedure type, technology and application.

Product Type Insights:

Kits

Laboratory Developed Tests (LDT)

Reagents and Consumables

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the product type. This includes kits, laboratory developed tests (LDT), and reagents and consumables. According to the report, kits represented the largest segment.

Procedure Type Insights:

Carrier Screening

Pre-Natal Screening

Pre-Implantation Genetic Testing

Infertility Genetic Testing

A detailed breakup and analysis of the reproductive genetics market based on the procedure type has also been provided in the report. This includes carrier screening, pre-natal screening, pre-implantation genetic testing, and infertility genetic testing. According to the report, carrier screening accounted for the largest market share.

Technology Insights:

Next-Generation Sequencing

Polymerase Chain Reaction

In Situ Hybridization (ISH/FISH)

Microarray

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the technology. This includes next-generation sequencing, polymerase chain reaction, in situ hybridization (ISH/FISH), and microarray. According to the report, next-generation sequencing represented the largest segment.

Application Insights:

Aneuploidy

Structural Chromosomal Abnormality

Single Gene Disorder

Others

A detailed breakup and analysis of the reproductive genetics market based on the application has also been provided in the report. This includes aneuploidy, structural chromosomal abnormality, single gene disorder, and others. According to the report, aneuploidy accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global reproductive genetics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global reproductive genetics market?
  • What is the impact of each driver, restraint, and opportunity on the global reproductive genetics market?
  • What are the key regional markets?
  • Which countries represent the most attractive reproductive genetics market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the reproductive genetics market?
  • What is the breakup of the market based on the procedure type?
  • Which is the most attractive procedure type in the reproductive genetics market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the reproductive genetics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the reproductive genetics market?
  • What is the competitive structure of the global reproductive genetics market?
  • Who are the key players/companies in the global reproductive genetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Reproductive Genetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Laboratory Developed Tests (LDT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Reagents and Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

  • 7.1 Carrier Screening
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pre-Natal Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pre-Implantation Genetic Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility Genetic Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Next-Generation Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 In Situ Hybridization (ISH/FISH)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Microarray
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Aneuploidy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Structural Chromosomal Abnormality
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Single Gene Disorder
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bangkok Genomics Innovation Public Company Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Centogene N.V.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Fulgent Genetics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Igenomix (Vitrolife Group)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Invitae Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 PerkinElmer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Reproductive Genetics Market: Major Drivers and Challenges
  • Figure 2: Global: Reproductive Genetics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Reproductive Genetics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Reproductive Genetics Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Reproductive Genetics Market: Breakup by Procedure Type (in %), 2023
  • Figure 6: Global: Reproductive Genetics Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Reproductive Genetics Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Reproductive Genetics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Reproductive Genetics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Reproductive Genetics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Reproductive Genetics (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Reproductive Genetics (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Reproductive Genetics (Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Reproductive Genetics (Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Reproductive Genetics (Pre-Natal Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Reproductive Genetics (Pre-Natal Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Reproductive Genetics (Infertility Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Reproductive Genetics (Infertility Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Reproductive Genetics (Next-Generation Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Reproductive Genetics (Next-Generation Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Reproductive Genetics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Reproductive Genetics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Reproductive Genetics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Reproductive Genetics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Reproductive Genetics (Aneuploidy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Reproductive Genetics (Aneuploidy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Reproductive Genetics (Single Gene Disorder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Reproductive Genetics (Single Gene Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Reproductive Genetics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Reproductive Genetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Reproductive Genetics Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Reproductive Genetics Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Reproductive Genetics Industry: Value Chain Analysis
  • Figure 90: Global: Reproductive Genetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Reproductive Genetics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Reproductive Genetics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Reproductive Genetics Market Forecast: Breakup by Procedure Type (in Million US$), 2024-2032
  • Table 4: Global: Reproductive Genetics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Reproductive Genetics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Reproductive Genetics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Reproductive Genetics Market: Competitive Structure
  • Table 8: Global: Reproductive Genetics Market: Key Players